Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Germany’s EV boom lifts global sales to record 11 million

    October 30, 2026

    Apple unveils MacBook Pro with OLED display and touchscreen

    October 29, 2026

    Integrated Identity Ranks in Top 0.1% with Flawless 100/100 Google PageSpeed

    October 29, 2026
    Facebook X (Twitter) Instagram
    Mozambique GazetteMozambique Gazette
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Mozambique GazetteMozambique Gazette
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research
    ACCESS Newswire

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    GA-ASI and Saab Perform Advanced AEW Flight Testing on Uncrewed MQ-9B

    October 28, 2026

    Chervon Appoints Stephen Sarnocinski to President – End User Research, Sales and Service – OPE Commercial Landscaping Market Global

    October 21, 2026

    OMP and Eastman Show Decision Velocity in Practice at Gartner Supply Chain Planning Summit 2026

    October 15, 2026

    ComplianceQuest and Zolon PCS Selected to Modernize U.S. Food and Drug Administration (FDA) Enterprise Quality Management System

    October 6, 2026

    Chervon Names Claudio Chiappetta Vice President of Retail Sales for Chervon Canada

    October 5, 2026

    A New Force in the Surf Park Economy

    September 8, 2026
    Latest News

    Germany’s EV boom lifts global sales to record 11 million

    October 30, 2026

    Apple unveils MacBook Pro with OLED display and touchscreen

    October 29, 2026

    Integrated Identity Ranks in Top 0.1% with Flawless 100/100 Google PageSpeed

    October 29, 2026

    Cyclone Arnab hits India’s east coast after mass evacuations

    October 29, 2026

    Brent tops $115 as US-Iran strike reports lift oil

    October 29, 2026

    UAE President receives flydubai crew from September incident

    October 28, 2026

    DR Congo Ebola cases top 10,000 in fastest-growing outbreak

    October 28, 2026

    Carney hosts Abu Dhabi Crown Prince at Ottawa dinner banquet

    October 28, 2026
    © 2026 Mozambique Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.